Geneva Capital Management LLC Decreases Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Geneva Capital Management LLC lessened its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 5.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 743,520 shares of the company’s stock after selling 44,958 shares during the quarter. Geneva Capital Management LLC’s holdings in Option Care Health were worth $17,250,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. UMB Bank n.a. boosted its stake in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares during the period. International Assets Investment Management LLC boosted its stake in shares of Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after buying an additional 2,757 shares during the period. Quarry LP boosted its stake in shares of Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after buying an additional 2,628 shares during the period. Blue Trust Inc. boosted its stake in shares of Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock valued at $109,000 after buying an additional 681 shares during the period. Finally, Venturi Wealth Management LLC boosted its stake in shares of Option Care Health by 2,621.3% in the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock valued at $110,000 after buying an additional 4,561 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $34.60 on Thursday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.85. The stock has a 50 day moving average of $29.38 and a two-hundred day moving average of $28.14. The stock has a market cap of $5.72 billion, a P/E ratio of 29.08, a P/E/G ratio of 2.30 and a beta of 1.33.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. UBS Group started coverage on Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective for the company. Barrington Research boosted their target price on Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. JPMorgan Chase & Co. boosted their target price on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. JMP Securities restated a “market outperform” rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Finally, Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $32.88.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.